#magicmushrooms
A Tampa, Floria, biotech startup studying whether magic mushrooms could treat illnesses has received $2.5 million from investors led by a Florida venture capital firm.

Psilera Bioscience researches whether there are healing properties in psychedelics, which trigger hallucinations and intensified feelings. Some scientists believe its ingredients — DMT, psilocybin and psilocin — may alleviate conditions that plague millions of Americans.
Think mental illness, addiction and even Alzheimer's disease.
"Current treatments for those illnesses aren't very effective," co-founder and CEO Chris Witowski said. "Psychedelics haven't been explored as an option since the 1970s. We now have the tools to see how the drugs function in the brain, and analyze if they're actually working."

#magicmushrooms A Tampa, Floria, biotech startup studying whether magic mushrooms could treat illnesses has received $2.5 million from investors led by a Florida venture capital firm. Psilera Bioscience researches whether there are healing properties in psychedelics, which trigger hallucinations and intensified feelings. Some scientists believe its ingredients — DMT, psilocybin and psilocin — may alleviate conditions that plague millions of Americans. Think mental illness, addiction and even Alzheimer's disease. "Current treatments for those illnesses aren't very effective," co-founder and CEO Chris Witowski said. "Psychedelics haven't been explored as an option since the 1970s. We now have the tools to see how the drugs function in the brain, and analyze if they're actually working."
Like
1
0 Comments 0 Shares 407 Views 0